In AML cells, TET3 expression was positively correlated with tumor suppressor gene expression, including CDKN2B, ZIC2, and miR-196a, and negatively correlated with oncogenes such as PAX2 and IL-2RA in AML specimens. The gene discussed is CDKN2B; the disease is acute myeloid leukemia.